IMCAS 2026 | FIMAN Continues to Deliver the Power of Chinese Collagen to the World

IMCAS ASIA 2026 was held in Bangkok, Thailand, from June 19 to 21. FIMAN showcased its full range of products under the FILLDERM and BIOYONCE brands at this world-leading academic aesthetic medicine conference.


Having first attended IMCAS in 2024, FIMAN has participated in this flagship global aesthetic medicine summit for consecutive years. On this occasion, the enterprise led more than 20 domestic aesthetic physicians to Thailand for cross-border academic exchanges. It presented China’s clinical application outcomes and proprietary technological breakthroughs in collagen to practitioners worldwide, demonstrating the research strength of China’s indigenous collagen industry.

At the conference, Dean Huang Jiaxin from Shurui Lai Medical Aesthetics delivered a keynote speech on the advancement of China’s collagen industry and its clinical application practices. He noted that collagen boasts over 40 years of clinical application history. Beyond its fundamental role in soft tissue augmentation, its merits in skin repair and endogenous anti-aging have been increasingly explored. Collagen perfectly aligns with Asians’ pursuit of gentle, natural anti-aging effects, fueling robust growth across China’s collagen sector.

Backed by a comprehensive industrial chain and massive domestic clinical data, China’s collagen-based aesthetic protocols have gained growing recognition within the international medical community. Moving forward, FIMAN will continue to delve deep into collagen technological innovation. Upholding its vision — “The world looks to China for collagen, and China looks to FIMAN”, the brand will steadily advance domestic medical-grade collagen onto the global stage, enabling China’s biomedical aesthetic research achievements to earn worldwide acclaim.